Zhu, Wenjing
Niu, Jumin
He, Miao
Zhang, Liwen
Lv, Xuemei
Liu, Fangxiao
Jiang, Longyang
Zhang, Jing
Yu, Zhaojin
Zhao, Lin
Bi, Jia
Yan, Yuanyuan
Wei, Qian
Huo, Hong
Fan, Yue
Chen, Yuzong
Ding, Jian
Wei, Minjie
Funding for this research was provided by:
National Natural Science Foundation of China (81572898, 81673475, 81502996, 81601370)
National Natural Science Foundation of China and Liaoning joint fund key program (U1608281)
The Drug Innovation Major Project (2018ZX09711001-008-006)
Key Laboratory Foundation from Shenyang S&T Projects (Z18-4-020)
Liaoning Province Scientific Research Foundation (LQNK20173, 20170541024, 20180550500)
Article History
Received: 9 May 2019
Accepted: 31 July 2019
First Online: 8 August 2019
Ethics approval and consent to participate
: Ethical approval has been obtained by The Cancer Genome Atlas (TCGA).
: Not applicable.
: The authors declare that they have no competing interests.